Here are four key points on the stock rise, according to the report:
1. Yesterday’s trading marks AmSurg’s market cap at $3.31 billion.
2. The company’s P/E ratio is 61.
3. Volume on the 52-week high was 309,118, and the stock has a float of 48.41 million shares, averaging a daily volume of $397,081.
4. AmSurg employs roughly 10,500 people under CEO Christopher A. Holden.
More articles on transactions and valuation issues:
7 things to know about Q1 healthcare M&A
MFC announce normal course issuer bid approval
The Children’s Hospital of Philadelphia officially opens ASC: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
